What VCs want before funding your AI startup in 2025
What Changed and Why It Matters Generative AI rewired venture calculus. Startups can ship more with fewer people and less cash. But the bar for proof is higher. “Virtually all…
Why AI drug startups are raising big as FDA tests faster reviews
What Changed and Why It Matters The U.S. FDA is piloting generative AI to support its drug review workflow. The agency’s goal: faster document triage, smarter search across prior decisions,…
How US chip bans spawned China’s booming GPU gray market for AI
What Changed and Why It Matters US export controls targeted Nvidia’s top AI chips. The goal: slow China’s AI progress. The result: a large, liquid gray market that keeps GPUs…